The Pregnancy in Polycystic Ovary Syndrome study: Baseline characteristics of the randomized cohort including racial effects
Legro RS, Myers ER, Barnhart HX, Carson SA, Diamond MP, Carr BR, et al. The Pregnancy in Polycystic Ovary Syndrome study: baseline characteristics of the randomized cohort including racial effects. Fertil Steril 2006;86:914-33.
Testosterone and mood dysfunction in women with polycystic ovarian syndrome compared to subfertile controls
Barry JA, Hardiman PJ, Saxby BK, Kuczmierczyk A. Testosterone and mood dysfunction in women with polycystic ovarian syndrome compared to subfertile controls. J Psychosom Obestet Gynaecol 2011;32:104-11.
Evaluation and treatment of hirsutism in premenopausal women: An Endocrine Society clinical practice guideline
Martin KA, Chang RJ, Ehrmann DA, Ibanez L, Lobo RA, Rosenfield RL, et al. Evaluation and treatment of hirsutism in premenopausal women: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2008;93:1105-20.
Disturbances in sexual differentiation of rat fetuses following spironolactone treatment
Hecker A, Hasan SH, Neumann F. Disturbances in sexual differentiation of rat fetuses following spironolactone treatment. Acta Endocrinolol (Copenh) 1980;95:540-5.
Prenatal alpha-difluoromethylornithine treatment: Effects on postnatal renal growth and function in the rat
Gray JA, Rehnberg BF, Rogers EH, Lau C, Slotkin TA, Kavlock RJ. Prenatal alpha-difluoromethylornithine treatment: effects on postnatal renal growth and function in the rat. Teratology 1989;40:105-11.
Clomiphene metformin or both for infertility in the polycystic ovary syndrome
Legro RS, Barnhart HX, Schlaff WD, Carr BR, Diamond MP, Carson SA, et al. Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med 2007;356: 551-66.
Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome
Taylor AE, McCourt B, Martin KA, Anderson EJ, Adams JM, Schoenfeld DH. Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome. J Clin Endocrinol Metab 1997;82:2248-56.
Degree of facial and body terminal hair growth in unselected black and white women: Toward a populational definition of hirsutism
DeUgarte CM, Woods KS, Bartolucci AA, Azziz R. Degree of facial and body terminal hair growth in unselected black and white women: toward a populational definition of hirsutism. J Clin Endocrinol Metab 2006;91:1345-50.
H. Total testosterone assays in women with polycystic ovary syndrome: Precision and correlation with hirsutism
Legro RS, Schlaff WD, Diamond MP, Coutifaris C, Casson PR, Brzyski RG, et al H. Total testosterone assays in women with polycystic ovary syndrome: precision and correlation with hirsutism. J Clin Endocrinol Metab 2010;95:5305-13.
Randomized, double-blind clinical evaluation of the efficacy and safety of topical eflornithine HCl 13.9% cream in the treatment of women with facial hair
Wolf JE Jr, Shander D, Huber F, Jackson J, Lin CS, Mathes, BM, et al. Randomized, double-blind clinical evaluation of the efficacy and safety of topical eflornithine HCl 13.9% cream in the treatment of women with facial hair. Int J Dermatol 2007;46:94-8.
The effect of metformin treatment for 2 years without caloric restriction on endocrine and metabolic parameters in women with polycystic ovary syndrome
Oppelt PG, Mueller A, Jentsch K, Kronawitter D, Reissmann C, Dittrich R, et al. The effect of metformin treatment for 2 years without caloric restriction on endocrine and metabolic parameters in women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes 2010;118:633-7.
Endocrinological markers for assessment of hyperandrogenemia in hirsute women
Mueller A, Cupisti S, Binder H, Hoffmann I, Kiesewetter F, Beckmann MW, et al. Endocrinological markers for assessment of hyperandrogenemia in hirsute women. Horm Res 2007;67:35-41.